A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer-Reference-Cited by-同舟云学术

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer

Published:2014-02-17 Issue:4 Volume:73 Page:799-806
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Chao Yee,Hsieh Jan-Sing,Yeh Hsien-Tang,Su Yu-Chieh,Wu Cheng-Chung,Chen Jen-Shi,Tai Cheng-Jeng,Bai Li-Yuan,Yeh Kun-Huei,Su Wu-Chou,Li Chung-Pin

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/article/10.1007/s00280-014-2407-y/fulltext.html

Reference27 articles.

1. Crew KD, Neugut AI (2006) Epidemiology of gastric cancer. World J Gastroenterol 12(3):354–362

2. Chiang CY, Huang KH, Fang WL, Wu CW, Chen JH, Lo SS, Hsieh MC, Shen KH, Li AF, Niu DM, Chiou SH (2011) Factors associated with recurrence within 2 years after curative surgery for gastric adenocarcinoma. World J Surg 35(11):2472–2478

3. Benson AB (2008) Advanced gastric cancer: an update and future directions. Gastrointest Cancer Res 2(4 Suppl):S47–S53

4. Ychou M, Astre C, Rouanet P, Fabre JM, Saint-Aubert B, Domergue J, Ribard D, Ciurana AJ, Janbon C, Pujol H (1996) A phase II study of 5-fluorouracil, leucovorin and cisplatin (FLP) for metastatic gastric cancer. Eur J Cancer 32A(11):1933–1937

5. Lin YC, Chen JS, Wang CH, Wang HM, Chang HK, Liaul CT, Yang TS, Liaw CC, Liu HE (2001) Weekly high-dose 5-fluorouracil (5-FU), leucovorin (LV) and bimonthly cisplatin in patients with advanced gastric cancer. Jpn J Clin Oncol 31(12):605–609

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902);International Journal of Clinical Oncology;2024-01-16

2. Biweekly CAPOX versus Triweekly CAPOX in the adjuvant therapy of post-surgery CRC: a randomized controlled trial;2023-06-26

3. Phase II study of S-1 plus docetaxel as first-line treatment for older patients with advanced gastric cancer (OGSG 0902);2023-06-01

4. Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases;Annals of Surgical Oncology;2022-09-07

5. A randomized phase II trial comparing capecitabine with oxaliplatin or docetaxel as first-line treatment in advanced gastric and gastroesophageal adenocarcinomas;Medicine;2021-04-30